Background. Cytomegalovirus (CMV) establishes a lifelong latent infection after primary infection and may reactivate periodically, with the shedding of infectious virus in body fluids. To better understand the prevalence and shedding model of CMV in immunocompetent seropositive women of childbearing age, a 6-month longitudinal study was conducted in healthy female college students.
Human cytomegalovirus (CMV) infection is very common.
After primary infection, CMV establishes a lifelong latent infection and may reactivate periodically with the shedding of infectious virus in saliva, urine, and other bodily secretions [1] . Maternal primary infection, reactivation, or reinfection with CMV during pregnancy may lead to congenital CMV infection, which is an important cause of sensorineural hearing loss and developmental delay in children. The dogma that congenitally infected children who are born to women with preexisting antibodies have normal outcomes has led to considerable underestimate of the disease burden due to congenital CMV infection in infants born to seropositive mothers. More-recent data indicate that congenital CMV infection following the reactivation or reinfection of CMV in seropositive mothers contributes significantly to the CMV-related disease burden, affecting 0.2%-2% of live births [2] . It was estimated that with population seroprevalence increasing from 30% to 95%, the proportion of congenital CMV infections attributable to nonprimary maternal infections increased from 57% to 96%, and the proportion of CMV-related hearing loss increased from 53% to 95% [3] .
Knowledge of the CMV secretion dynamics in women of reproductive age not only is important for understanding the natural history and pathogenesis of CMV, but also is helpful for designing strategies to prevent and control congenital CMV infection. Currently available data regarding the CMV shedding pattern in adults were mainly obtained from pregnant women and postpartum women, and these populations were either immunocompromised or were taking care of infants and thus had a high risk of CMV infection [1, 4] . The reported prevalence of CMV shedding in these cohorts ranged from 3% to 83%, depending on the sample types collected and length of the follow-up period. It is of interest to understand the CMV shedding model in immunocompetent seropositive women of childbearing age with a very low risk of CMV infection, which might be closer to the natural dynamics of CMV in the host, as these data are currently very rare. To fulfill these knowledge gaps, a 6-month longitudinal study was conducted in healthy female college students.
METHODS

Study Population
Female undergraduate or postgraduate students who were 18-30 years old and not pregnant were recruited in October 2014 from Xiamen University by a variety of recruitment methods, including leaflets, e-mail list announcements, and on-site M A J O R A R T I C L E recruitment. At enrollment, sociodemographic information was collected, including student identity, student status (undergraduate or postgraduate), dormitory address, age, marital status, and pregnancy history.
The study was approved by the Ethical Committee of the School of Public Health, Xiamen University. Informed consent was obtained from each participant at the time of enrollment.
Follow-up and Sample Collection
This was a 6-month longitudinal study. A total of 12 face-toface visits for sample collection and an update on pregnancy status were conducted every 2 weeks after enrollment, except that the mean interval between the eighth and ninth visit was 36 days (23-45 days), owing to the Chinese Spring Festival holiday. Saliva and urine samples were collected during each visit. For saliva collection, a swab was placed in the mouth for at least 3 minutes to ensure adequate saliva stimulation, which was then extruded into a collection tube. Midstream clean urine samples were collected into sterile tubes. Serum specimens were collected at the first visit and the 12th (final) visit. All specimens were stored at −80°C in a refrigerator until testing.
Laboratory Testing
Serum samples were tested for the CMV immunoglobulin G (IgG) antibody by a well-validated enzyme-linked immunosorbent assay as previously reported [5] . The antibody level was quantified using a working reference serum calibrated by a CMV IgG standard serum (product code 12/1996) supplied by the Paul Ehrlich Institute (Federal Institute for Vaccines and Biomedicines, Langen, Germany).
Saliva and urine samples were tested for CMV DNA. DNA in saliva and urine was extracted using the Virus Total Nucleic Acid Isolation Kit (GenMag Biological Technology) and an automatic DNA extraction and purification system (product code NP968; TianLong Technology). The presence of CMV DNA was then tested by a real-time polymerase chain reaction (PCR) assay conducted on a Bio-rad CFX96TM instrument. The forward primer was 5′-GCTCCTCTGATTCTCTGGTGTC-3′, the reverse primer was 5′-ACTGTTCTCAGCCACAATTACTG-3′, and the probe was FAM-5′-CCCCAGAGTCCCCTGTACCCGC-3′-BHQ1. Specimens with typical amplification signals were considered positive, regardless of the cycle number. The lower detection limit of the assay is 50 IU/mL, calibrated with the World Health Organization international standard for human CMV nucleic acid amplification techniques (National Institute for Biological Standards and Control code 09/162). The linear range of the assay is 500-5 × 10 6 IU/mL, with a cycle threshold range of 37-23.
Statistical Analysis
An episode of CMV shedding was considered to be occurring if CMV DNA was detected in saliva and/or urine samples. Lasting viral shedding was defined when CMV DNA was detected in 2 consecutive saliva and/or urine specimens. Continuous variables were described using mean values and standard deviations if they showed a normal distribution; otherwise, they were described using median values and ranges. Categorical variables were described using absolute numbers and prevalences. A logistic regression model was performed to evaluate the risk factors associated with CMV shedding. All statistical analyses were performed using SAS software (version 9.1; SAS Institute, Cary, NC).
RESULTS
Sociodemographic Characteristics of Participants
A total of 102 female students, 50 undergraduates and 52 postgraduates, were enrolled (Table 1) and followed up for 6 months at 2-week intervals, yielding 12 visits. The mean age (±SD) was 22.2 ± 2.6 years. All students were unmarried and not pregnant. Among them, 98 students lived in the school dormitory, 2 students lived alone, and 2 students lived at home. During the visits 1-7, the follow-up rates were ≥98%. From then until the end of the study, the follow-up rates were >93%, except for the rate at visit 8 (85%), which was at the end of the fall semester.
CMV Shedding
During the 6-month follow-up period, CMV shedding occurred in 30 participants (29.4%; Figure 1) , with CMV DNA detected in saliva or urine. The 6-month CMV shedding rates in saliva and urine were 21.6% (in 22 of 102 participants) and 10.8% (in 11 of 102), respectively. Virus DNA has never been detected in both saliva and urine samples from a participant at the same visit. Thirteen participants excreted the virus more than once, with 10 excreting virus in saliva only (for 8 participants) or urine only (for 2) and 3 excreting virus in both saliva and urine but at different visits. Seven participants (6.7%) shed virus for ≥2 weeks. The longest viral shedding period was 43 days. The CMV shedding prevalence at different visits varied from 2.0% to 10.4%, and the average was 4.7% (Figure 1 ). The prevalence rate at visit 9 (10.4%) was significantly higher than the average rate at other visits (3.9%; 95% confidence interval [CI], 2.9%-5.3%; P = .003). From visits 8 to 9, the virus shedding rate sharply rose, from 5.7% to 10.4%, and then declined to 2.0% at visit 10. The quantity of CMV shedding was low (range, 50-500 to 12428.4 IU/mL, with a PCR cycle threshold ranging from 43 to 33) through the study.
Anti-CMV IgG Antibody Levels
Serum specimens from 102 participants (100%) and 94 (92.2%) were collected at the initial and last visits, respectively. Except for 3 baseline serum specimens, which were inadequate for antibody testing, anti-CMV IgG antibody was detected in all tested serum specimens, with a positivity rate of 100% (95% CI, 96.3%-100%). At baseline, the anti-CMV IgG antibody levels were between 0.47 and 100.79 IU/mL, with a geometric mean concentration of 17.43 IU/mL. Six months later, at the last visit, the antibody level was 0.26-2.63 times higher, for an average of 0.91 times higher, than the baseline level ( Figure 2 ). The baseline anti-CMV IgG levels were not statistically correlated with CMV shedding by participants.
DISCUSSION
The seropositive rate of female college students was 100% (95% CI, 96.3%-100%) in the present study, in line with the findings of other studies, which showed that 94%-99% of pregnant women in China were seropositive [6] [7] [8] [9] . Our data showed that transient CMV shedding was common in saliva and/or urine in healthy seropositive young women sheltered from exogenous infectious sources and that the viral load was low and did not induce marked antibody increases. The baseline anti-CMV IgG level was not found to be associated with viral shedding. Previous studies focused more on viral shedding characteristics after primary CMV infection in healthy women, which indicated that CMV was secreted into saliva, urine, and vaginal fluid intermittently for several months or even years after anti-CMV seroconversion [10, 11] ; however, data on the dynamics of viral shedding in seropositive women are very limited. In the current study of healthy seropositive female college students, 29.4% of the participants shed CMV intermittently during the 6-month follow-up. We found that the CMV shedding prevalence among college students was between 2.0% and 10.4% at each visit. Arora et al [5] also detected intermittent CMV shedding in 83% of young seropositive postpartum women during visits every 6 months over a 3-year follow-up period, with a DNA prevalence S  20  21  22  23  24  25  26  27  28  29  30 V2 V3 V4 V5 V6 V7 V8 V9 V10 V11 V12 Shedding prevalence (%) Figure 1 . Cytomegalovirus (CMV) shedding prevalence and patterns during the follow-up period. The light blue stripe represents the 95% confidence interval of the average prevalence, excluding visit 9 (V9). No participant excreted the virus in both bodily fluids at the same visit. S, shedding in saliva; U, shedding in urine; ×, loss to follow-up. * The prevalence rate was significantly higher than the average rate at other visits. of 24%-45% at each visit. The participants in that study were young (mean age, 18 years), were black, had a low income level, were unmarried, and had 1 previous pregnancy; therefore, the greater frequency of virus shedding reported by Arora et al as compared to that in our study might have due to the high risk of superinfection by exogenous CMV strains during sexual activity and caring for newborns. It is interesting that similar intermittent virus shedding was also observed for herpes simplex virus (HSV), another member of family Herpesviridae [12] . In that study, HSV DNA was detected in 14% of genital samples and 7% of oral samples by repeated measures 4 times a day for 60 days, and nearly half of HSV mucosal reactivations last <12 hours, which indicated that the virus shedding model was characterized by frequent onset and rapid clearance.
In humans with latent CMV infection, the salivary glands and kidneys are important sites of carriage of the virus [13] . Our study showed that nearly one third of the cohort had detectable CMV DNA in saliva or urine, the viral load was very low, and no participant had detectable CMV DNA in saliva and urine at the same visit. It hinted that excreted virus in salivary glands or renal epithelia cells did not enter the blood circulatory system or that the quantity was too limited to reach the other body site. It was in line with another finding in the current study that no marked increase in the antibody level was observed in participants with virus shedding during the follow-up period, which indicated that no additional virus appeared in the circulation system to activate the anamnestic humoral immune response. The baseline anti-CMV IgG level was not correlated with CMV shedding in present study, but the high level of antibody prior to transplantation was reported to be related to detection of HSV excretion after transplantation [14] . The authors suggested that the high level of antibody was associated with frequent antigenic stimulation, combined with frequent HSV viremia.
In the present study, no ≥4-fold increase in the antibody level after the 6-month follow-up period was observed. In contrast, Li et al [15] reported that 8.5% of the seropositive women of childbearing age in a rural population of China had a marked increase in anti-CMV IgG titer over 1 year. The paradoxical serological findings in women living in a sheltered setting as compared to those in the general population raise an interesting hypothesis that the abnormal increase of the antibody level observed in individuals living in the general community is more likely to be induced by newly acquired CMV infection instead of endogenous CMV reactivation of latent infection. It will be worthwhile to test this hypothesis in future studies.
The CMV shedding prevalence at different visits varied from 2.0% to 10.4%. The prevalence rate at visit 9 (10.4%) was significantly higher than the average rate at other visits (P < .05; Figure 1 ). Visit 9 was conducted after the Chinese Spring Festival vacation, during which all participants visited their family; 8 of 10 participants positive for CMV at visit 9 were negative at visit 8. The reason for the abnormally high prevalence is not clear.
One possible explanation is that the reunion with family raised the risk of contact exogenous virus by contact with children living in their family or in the community, since CMV excretion in saliva and urine can continue for months or years in young children [16, 17] . Unfortunately, the low viral load in the samples makes it impossible to compare sequences of excreted viruses. The fluctuation of shedding rates at different time points suggested that data from small-scale cross-sectional studies should be carefully interpreted.
Most participants (96.1% [98 of 102]) enrolled in our study lived in the female-only dormitory of the university, with limited contact with young children and sexual activity among residents. The strength of this cohort is its inclusion of women with low risk of exposure to exogenous infectious sources, although its representativeness of the general population of young women of reproductive age is limited. Additional limitations of this study include the small sample size and the relatively short follow-up period. Vaginal samples could not be collected owing to practical considerations, even though the prevalence of viral shedding is highest in vaginal fluid [1] .
In conclusion, the presented data indicated that the physiologically low levels of CMV shedding in saliva and urine are common and intermittent and do not stimulate an anamnestic antibody response in seropositive immunocompetent women of childbearing age sheltered from infectious sources. The shedding characteristics in seropositive pregnant women and their relationship to the risk of vertical transmission need to be further investigated. 
